Process scale up

Process scale up
Product Description

Siegfried Ltd. offers wide range of products and services which includes process scale up. Contact us for more information.

Siegfried AG

  • CH
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator

Siegfried AG

  • CH
  • 2015
    On CPHI since
  • 3
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator

More Products from Siegfried AG (26)

  • Latanoprost

    Product Latanoprost

    Siegfried Ltd. offers wide range of products and services which includes latanoprost. Therapeutic areas: glaucoma / ocular hypertension. Contact us for more information.
  • Montelukast

    Product Montelukast

    Siegfried Ltd. offers wide range of products and services which includes montelukast. Therapeutic areas: asthma. Contact us for more information.
  • Nifedipine

    Product Nifedipine

    Siegfried Ltd. offers wide range of products and services which includes nifedipine. Therapeutic areas: hypertension. Contact us for more information.
  • Olanzapine

    Product Olanzapine

    Siegfried Ltd. offers wide range of products and services which includes olanzapine. Therapeutic areas: schizophrenia / bipolar disorder. Contact us for more information.
  • Phase iv marketing trial repackaging

    Product Phase iv marketing trial repackaging

    Siegfried Ltd. offers wide range of products and services which includes phase iv marketing trial repackaging. Contact us for more information.
  • Process development

    Product Process development

    Siegfried Ltd. offers wide range of products and services which includes process development. Contact us for more information.
  • sterilization development and validation

    Product sterilization development and validation

    Siegfried Ltd. offers wide range of products and services which includes sterilization development and validation. Contact us for more information.
  • Tamsulosine

    Product Tamsulosine

    Siegfried Ltd. offers wide range of products and services which includes tamsulosine. Therapeutic areas: benign prostate hyperplasia. Contact us for more information.
  • Travoprost

    Product Travoprost

    Siegfried Ltd. offers wide range of products and services which includes travoprost. Therapeutic areas: glaucoma / ocular hypertension. Contact us for more information.
  • Amlodipine besylate

    Product Amlodipine besylate

    Siegfried Ltd. offers wide range of products and services which includes amlodipine besylate. Therapeutic areas: hypertension. Contact us for more information.
  • Amlodipine mesylate

    Product Amlodipine mesylate

    Siegfried Ltd. offers wide range of products and services which includes amlodipine mesylate. Therapeutic areas: hypertension. Contact us for more information.
  • API Catalog

    Product API Catalog

    View our API Catalog to browse all our API portfolio products.

    API catalog - Siegfried

Siegfried AG resources (9)

  • News On track at CPHI Barcelona - The Track Sponsor interviews: Siegfried

    In our packed out content sessions at CPHI Barcelona this year we focus on some of the hottest topics coming up in the pharma industry, with each track sponsored by a leading expert in the field. 
  • Webinar From Lab to Commercial Production -How to Combat Challenges in OSD High Potency Products Development

    Highly Potent APIs are a rapidly growing segment of the global pharmaceutical industry, and they are acquiring a significant relevance into the development space. The importance to understand the challenges around development of High Potency Oral solids formulations, are the key to ensure a right scale-up and launch Risk-based approach: measuring the risk, not the hazard Challenges for High potency products handling. Importance of select the adequate partner Development of secure and scalable process in high containment environment
  • News Siegfried starts to ramp up production after cyber attack

    Hameln plant which provides fill and finish for Pfizer-BioNTech COVID-19 shot should be fully operational within the week, CDMO says
  • Webinar Building a Collaborative Supply Chain for Biological Products: A Roadmap for the Future

    The Covid-19 Pandemic forced us to learn new ways of collaborating and innovating to solve a global crisis - what can we learn and leverage from this experience as we adapt to a 'new normal'?
    Amazing scientific development and break-throughs are evolving faster than ever, with new advanced treatment options for patients being developed at unprecedented speed. All of us involved in manufacturing and supply need to rethink how we collaborate, deliver medicines and learn faster.
    No one company can solve this alone - requiring us to collaborate, innovate and learn in new ways. What does this change really mean for us? Welcome to engage in a discussion, sharing case study data and recent insights in the middle of an industry learning journey.
  • Webinar Process Optimization for Viral Vector Manufacturing

    Though viral vectors are used extensively in cell and gene therapy, the challenges of manufacturing such complex biologics at industrial scale is still a limitation to its broader use.
    Dr. Ayuso will speak about how upstream and downstream process optimization using design of experiments (DOE), a platform approach and end-to-end capabilities can tackle manufacturing challenges and help to expedite drug development.
  • Webinar Keynote Address: Next-Gen Biomanufacturing

    Join Asklepios BioPharmaceutical's former CEO Shelia Ann Mikhail, where she will Set the Scene for the latest innovations and developments affecting the Biomanufacturing Landscape
  • Webinar Overcoming Challenges in Transferring a Sterile Biologics Drug Product to a CDMO

    Ensuring quality and compliance in bio-manufacturing Closing gaps in development data prior to the first GMP production Adjusting manufacturing processes throughout the course of a site-to-site transfer Fulfilling special requirements on container closure systems for biologics Transferring analytical methods for drug products and drug substances
  • Webinar Building a Collaborative Supply Chain for Biological Products: A Roadmap for the Future

    The Covid-19 Pandemic forced us to learn new ways of collaborating and innovating to solve a global crisis - what can we learn and leverage from this experience as we adapt to a new normal? Amazing scientific development and break-throughs are evolving faster than ever, with new advanced treatment options for patients being developed at unprecedented speed. All of us involved in manufacturing and supply need to rethink how we collaborate, deliver medicines and learn faster.
    No one company can solve this alone - requiring us to collaborate, innovate and learn in new ways. What does this change really mean for us? Welcome to engage in a discussion, sharing case study data and recent insights in the middle of an industry learning journey.
  • Webinar "Panel: Strategies for Commercialising Cell and Gene Therapies"

    Manufacturers face unique quality challenges that can hinder progress. In this session, discover quality challenges in Cell and Gene Therapy (CGT) and learn common practices for overcoming them:
    Where are all the approvals? Understanding unique manufacturing challenges for Autologous Cell Therapies How does development by design, quality by design, and Cell Therapy COGs converge in this new space? Creating a Cell Therapy technology roadmap to address challenges and drive speed-to-market